Abstract
Prostate cancer is aheterogeneous disease. In cases of low-risk prostate cancer, active surveillance represents an attractive alternative treatment. Significant complications of a definitive treatment can therefore be delayed or completely avoided. Despite strict inclusion criteria for active surveillance, the diagnosis of low-risk prostate cancer can be inaccurate and there is therefore arisk of missing the optimal point in time for definitive treatment. Multimodal diagnostics and continuous aftercare are therefore crucial.
| Dokumententyp: | Zeitschriftenartikel |
|---|---|
| Fakultät: | Medizin |
| Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
| ISSN: | 0340-2592 |
| Sprache: | Deutsch |
| Dokumenten ID: | 80380 |
| Datum der Veröffentlichung auf Open Access LMU: | 15. Dez. 2021 14:53 |
| Letzte Änderungen: | 15. Dez. 2021 14:53 |
